Steinar Lundgren

6.2k citations

104 papers · 4.1k indexed · h-index 37

Impact in

Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
Radiology, Nuclear Medicine and Imaging top 1%
- MRI in cancer diagnosis
- Advanced MRI Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging

Papers in ⓘ

Radiology, Nuclear Medicine and Imaging 38
- MRI in cancer diagnosis 20
- Advanced MRI Techniques and Applications 16
- Radiomics and Machine Learning in Medical Imaging 12
Cancer Research 23
- Breast Cancer Treatment Studies 17

Co-authors: Tone F. Bathen (28 shared papers)Ingrid S. Gribbestad (20 shared papers)Beathe Sitter (13 shared papers)Hans E. Fjøsne (13 shared papers)Per Eystein Lønning (21 shared papers)Stener Kvinnsland (10 shared papers)Guro F. Giskeødegård (12 shared papers)Jostein Halgunset (4 shared papers)
Journals: Acta Oncologica (9 papers)NMR in Biomedicine (7 papers)BMC Cancer (5 papers)Acta Radiologica (4 papers)Breast Cancer Research and Treatment (4 papers)
Partner nations: Norway United States United Kingdom

In The Last Decade

Steinar Lundgren

100 papers receiving 4.0k citations

Peers

Countries citing papers authored by Steinar Lundgren

Since Specialization

Citations

This map shows the geographic impact of Steinar Lundgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steinar Lundgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steinar Lundgren more than expected).

Fields of papers citing papers by Steinar Lundgren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steinar Lundgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steinar Lundgren. The network helps show where Steinar Lundgren may publish in the future.

Co-authors

The 25 scholars most cited alongside Steinar Lundgren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steinar Lundgren Line = papers co-authored together Steinar Lundgren links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer British Journal of Cancer ·Jürgen Geisler, Nicholas King, Mitch Dowsett, Lars Ottestad, Steinar Lundgren, P. Walton, P.O. Kormeset, Per Eystein Lønning	1996	288
2	A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer * European Journal of Cancer ·W. Jonat, Anthony Howell, Carl Blomqvist, W. Eiermann, Gerard Winblad, C. Tyrrell, L. Mauriac, Henri Roché, Steinar Lundgren, Richard Hellmund, M. Azab	1996	207
3	Distribution of 4-hydroxy-N-desmethyltamoxifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment. PubMed ·Ernst A. Lien, Einar Solheim, Oscar A. Lea, Steinar Lundgren, Stener Kvinnsland, Per Magne Ueland	1989	196
4	Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters NMR in Biomedicine ·Beathe Sitter, Steinar Lundgren, Tone F. Bathen, Jostein Halgunset, Hans E. Fjøsne, Ingrid S. Gribbestad	2005	179
5	Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI European Radiology ·Kjell Arne Kvistad, Jana Rydland, H. -B. Smethurst, Steinar Lundgren, Hans E. Fjøsne, Olav Haraldseth	2000	146
6	Metabolic characterization of triple negative breast cancer BMC Cancer ·Maria Dung Cao, Santosh Lamichhane, Steinar Lundgren, Anna M. Bofin, Hans E. Fjøsne, Guro F. Giskeødegård, Tone F. Bathen	2014	123
7	Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism Annals of Oncology ·Jennifer Gjerde, Marianne Hauglid, Harald Breilid, Steinar Lundgren, Jan Erik Varhaug, Elton R. Kisanga, Gunnar Mellgren, Vidar M. Steen, Ernst A. Lien	2007	122
8	Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy NMR in Biomedicine ·Beathe Sitter, Tone F. Bathen, Trond E. Singstad, Hans E. Fjøsne, Steinar Lundgren, Jostein Halgunset, Ingrid S. Gribbestad	2010	114
9	Psychosocial interventions as part of breast cancer rehabilitation programs? Results from a systematic review Psycho-Oncology ·Egil A. Fors, Gro F. Bertheussen, Inger Thune, Lene Kristine Juvet, Ida‐Kristin Ørjasæter Elvsaas, Line Oldervoll, Gun Anker, Sture Falkmer, Steinar Lundgren, Gunnar Leivseth	2010	106
10	Multivariate Modeling and Prediction of Breast Cancer Prognostic Factors Using MR Metabolomics Journal of Proteome Research ·Guro F. Giskeødegård, Maria Tunset Grinde, Beathe Sitter, David E. Axelson, Steinar Lundgren, Hans E. Fjøsne, Steinar Dahl, Ingrid S. Gribbestad, Tone F. Bathen	2009	105
11	MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status Breast Cancer Research and Treatment ·Tone F. Bathen, Line R. Jensen, Beathe Sitter, Hans E. Fjøsne, Jostein Halgunset, David E. Axelson, Ingrid S. Gribbestad, Steinar Lundgren	2006	104
12	Dynamic contrast‐enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer NMR in Biomedicine ·Jose R. Teruel, Mariann Gjervik Heldahl, Pål Erik Goa, Martin D. Pickles, Steinar Lundgren, Tone F. Bathen, Peter Gibbs	2014	104
13	Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. PubMed ·I S Gribbestad, Beathe Sitter, Steinar Lundgren, J. Krane, David E. Axelson	1999	103
14	Merging transcriptomics and metabolomics - advances in breast cancer profiling BMC Cancer ·Eldrid Borgan, Beathe Sitter, Ole Christian Lingjærde, Hilde Johnsen, Steinar Lundgren, Tone F. Bathen, Thérese Sørlie, Anne‐Lise Børresen‐Dale, Ingrid S. Gribbestad	2010	92
15	Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE‐MRI Journal of Magnetic Resonance Imaging ·Roar Johansen, Line R. Jensen, Jana Rydland, Pål Erik Goa, Kjell Arne Kvistad, Tone F. Bathen, David E. Axelson, Steinar Lundgren, Ingrid S. Gribbestad	2009	90
16	Predictive and Prognostic Impact of TP53 Mutations and MDM2 Promoter Genotype in Primary Breast Cancer Patients Treated with Epirubicin or Paclitaxel PLoS ONE ·Ranjan Chrisanthar, Stian Knappskog, Erik Løkkevik, Gun Anker, Bjørn Østenstad, Steinar Lundgren, Terje Risberg, Ingvil Mjaaland, Gudbrand Skjønsberg, Turid Aas, Ellen Schlichting, Hans E. Fjøsne, Arne Nysted, Johan R. Lillehaug, Per Eystein Lønning	2011	81
17	Predicting long‐term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling NMR in Biomedicine ·Maria Dung Cao, Beathe Sitter, Tone F. Bathen, Anna M. Bofin, Per Eystein Lønning, Steinar Lundgren, Ingrid S. Gribbestad	2011	77
18	CHEK2 Mutations Affecting Kinase Activity Together With Mutations in TP53 Indicate a Functional Pathway Associated with Resistance to Epirubicin in Primary Breast Cancer PLoS ONE ·Ranjan Chrisanthar, Stian Knappskog, Erik Løkkevik, Gun Anker, Bjørn Østenstad, Steinar Lundgren, Elisabet O. Berge, Terje Risberg, Ingvil Mjaaland, Lovise Mæhle, Lars Engebretsen, Johan R. Lillehaug, Per Eystein Lønning	2008	75
19	Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy BMC Cancer ·Maria Dung Cao, Guro F. Giskeødegård, Tone F. Bathen, Beathe Sitter, Anna M. Bofin, Per Eystein Lønning, Steinar Lundgren, Ingrid S. Gribbestad	2012	71
20	Breast Lesions: Evaluation with Dynamic Contrast-enhanced T1-weighted MR Imaging and with T2-weighted First-Pass Perfusion MR Imaging Radiology* ·Kjell Arne Kvistad, Jana Rydland, Jyrki Vainio, Hanne B. Smethurst, Steinar Lundgren, Hans E. Fjøsne, Olav Haraldseth	2000	65

About Steinar Lundgren

Steinar Lundgren is a scholar working on Radiology, Nuclear Medicine and Imaging, Cancer Research, Oncology, Genetics and Pharmacology, having authored 104 papers that have together received 4.1k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (27 papers), MRI in cancer diagnosis (20 papers), Breast Cancer Treatment Studies (17 papers), Advanced MRI Techniques and Applications (16 papers), Metabolomics and Mass Spectrometry Studies (12 papers), Radiomics and Machine Learning in Medical Imaging (12 papers), Cancer survivorship and care (11 papers) and Cancer Treatment and Pharmacology (8 papers). The work is most often cited by research in Cancer Research (1.3k citations), Radiology, Nuclear Medicine and Imaging (1.0k citations), Oncology (1.2k citations), Genetics (1.1k citations) and Pharmacology (297 citations). Steinar Lundgren has collaborated with scholars based in Norway, United States and United Kingdom. Frequent co-authors include Tone F. Bathen, Ingrid S. Gribbestad, Beathe Sitter, Hans E. Fjøsne, Per Eystein Lønning, Stener Kvinnsland, Guro F. Giskeødegård, Jostein Halgunset, Ernst A. Lien and Kjell Arne Kvistad. Their work appears in journals such as Acta Oncologica, NMR in Biomedicine, BMC Cancer, Acta Radiologica and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact